Yulin Leng
No. 39 Shi Er Qiao Road
Chengdu, 610072, China
Chengdu, 610072, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Integrated LC-MS/MS profiling, network pharmacology and experimental validation reveal inhibition of the IL-6/JAK2/STAT3 pathway by Shenqi Compound in comorbid chronic pancreatitis and type 2 diabetes mellitus.
Journal: Journal of ethnopharmacology
Published: June 14, 2026
Peripheral blood HIF-1α levels in type 2 diabetes mellitus and their association with diabetic complications: a systematic review and meta-analysis.
Journal: Frontiers in endocrinology
Published: May 12, 2026
The role of peripheral blood HIF-1α in pancreatic β-cell dysfunction and insulin resistance among patients with type 2 diabetes: a systematic review and meta-analysis.
Journal: Frontiers in nutrition
Published: December 08, 2025
Puerarin as a multi-targeted modulator of lipid metabolism: molecular mechanisms, therapeutic potential and prospects for nutritional translation.
Journal: Frontiers in nutrition
Published: March 24, 2025
Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine.
Journal: Frontiers in pharmacology
Published: November 05, 2024
Relationship between stroke and estimated glucose disposal rate: results from two prospective cohort studies.
Journal: Lipids in health and disease
Published: October 08, 2024
Inhibited hypoxia-inducible factor by intraoperative hyperglycemia increased postoperative delirium of aged patients: A review.
Journal: Medicine
Published: September 11, 2024
Mendelian randomization analysis reveals causal factors behind diabetic nephropathy: evidence, opportunities, and challenges.
Journal: Frontiers in endocrinology
Published: June 06, 2024
The efficacy and safety of Ginkgo biloba L. leaves extract combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta-analysis of 41 randomized controlled trials.
Journal: Frontiers in pharmacology
Published: March 28, 2024
The potential of astragalus polysaccharide for treating diabetes and its action mechanism.
Journal: Frontiers in pharmacology
Published: November 16, 2023
Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Frontiers in cardiovascular medicine
Published: September 07, 2023
Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress.
Journal: Frontiers in pharmacology
Published: September 06, 2023
Last Updated: 09/26/2026